Concord Medical Services (NYSE:CCM) and Oncology Institute (NASDAQ:TOI)


Concord Medical Services (NYSE:CCM – Get Rating) and Oncology Institute (NASDAQ:TOI – Get Rating) are both small-cap medical companies, but which company is superior? We’ll compare the two companies based on their dividend strength, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings from Concord Medical Services and Oncology Institute, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Concorde Medical Services 0 0 0 0 N / A
Institute of Oncology 0 0 0 0 N / A

Risk and Volatility

Concord Medical Services has a beta of -0.13, which means its stock price is 113% less volatile than the S&P 500. In comparison, Oncology Institute has a beta of 1.65, which means its stock price is 65% more volatile than the S&P 500.

Benefits and evaluation

This table compares revenue, earnings per share, and valuation of Concord Medical Services and Oncology Institute.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Concorde Medical Services $34.18 million 2.15 -$47.51 million N / A N / A
Institute of Oncology $203.00 million 2.85 -$10.93 million N / A N / A

Oncology Institute has higher revenue and profit than Concord Medical Services.

Profitability

This table compares the net margins, return on equity and return on assets of Concord Medical Services and Oncology Institute.

Net margins Return on equity return on assets
Concorde Medical Services N / A N / A N / A
Institute of Oncology N / A 78.66% 7.84%

Insider and Institutional Ownership

0.4% of Concord Medical Services shares are held by institutional investors. 46.5% of the shares of Concord Medical Services are held by insiders of the company. Strong institutional ownership indicates that large fund managers, hedge funds, and endowments believe a company will outperform the market over the long term.

Summary

Oncology Institute beats Concord Medical Services on 6 out of 8 factors compared between the two stocks.

About Concord Medical Services (Get an assessment)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiation therapy and diagnostic imaging centers in the People’s Republic of China. The Company operates in two segments, Network and Hospital. Its services include Linear Accelerator Beam External Radiation Therapy, Gamma Knife Radiosurgery, Head Gamma Knife Systems, Body Gamma Knife Systems and Diagnostic Imaging Services. The Company’s other diagnostic treatments and services include CT scanners and emission CT scanners for diagnostic imaging, electroencephalography for the diagnosis of epilepsy and ultrasound therapy. In addition, it provides clinical support services, such as the development of treatment protocols for doctors, the organization of joint diagnosis between doctors in its network and clinical research, as well as assistance in recruitment. and determining the remuneration of physicians and other medical personnel. In addition, the Company provides hospitals with radiotherapy and diagnostic equipment rental, management services and premium cancer and proton treatment services, as well as teleconsultation and medical information technology services; and sells medical equipment. In addition, it operates specialized cancer hospitals, which provide radiotherapy services, diagnostic imaging services, chemotherapy and surgery. As of December 31, 2020, it operates a network of 27 cooperative centers located in 20 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, People’s Republic of China.

About the Institute of Oncology (Get an assessment)

The Oncology Institute, Inc., an oncology society, provides medical oncology services in the United States. Its services include medical services, in-house infusion and dispensary, clinical trial services, radiation therapy, outpatient stem cell transplant and transfusion programs, and patient support. The Company also offers and manages clinical trial services, such as clinical trial management, palliative care programs and stem cell transplant services. It serves adult and senior cancer patients. The company operates 67 clinics. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.



Get news and reviews for Concord Medical Services Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Concord Medical Services and related companies with MarketBeat.com’s free daily email newsletter.